UniProt P66034
P66034
P66034 (UniProt P66034): 12 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P66034
- Experimental structures
- 12
- Predicted models
- 0
Structures
12 records of P66034 in the MolNFT archive: 12 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2C92 | Lumazine synthase from mycobacterium tuberculosis bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C92 | Lumazine synthase from mycobacterium tuberculosis bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C94 | LUMAZINE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO 3-(1,3,7… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C94 | Lumazine synthase from mycobacterium tuberculosis bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C97 | LUMAZINE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO 4-(6… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C97 | Lumazine synthase from mycobacterium tuberculosis bound to 4-(6… | x-ray diffraction | A, B, C, D, E | — | — |
| 2C9B | Lumazine Synthase from Mycobacterium tuberculosus Bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 2C9B | Lumazine synthase from mycobacterium tuberculosus bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 2C9D | Lumazine Synthase from Mycobacterium tuberculosis Bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 2C9D | Lumazine synthase from mycobacterium tuberculosis bound to 3-(1,3,7… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 2VI5 | LUMAZINE SYNTHASE FROM MYCOBACTERIUM TUBERCULOSIS BOUND TO… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
| 2VI5 | Lumazine synthase from mycobacterium tuberculosis bound to N-6… | x-ray diffraction | A, B, C, D, E, F, G, H, I, J | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.